Euroespes (EEP.MC) Stock Price

Euroespes Price

CLOSED
0.34
​
Market closed

Revenue at Euroespes has contracted by 1.0% per year over the past 15 years to 2.88 M EUR. Earnings per share have declined at 26.2% per year over the last 15 years. Euroespes's net margin stands at 0.0%, up from -5.6% several years earlier.

Euroespes stock price

Access this data via the Eulerpool API

Euroespes business model & stock analysis

EuroEspes SA engages in the provision of biomedical services. The company is headquartered in Bergondo, La Coruna. The company went IPO on 2012-06-21. The firm operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Company’s medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The firm operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.

Frequently asked questions about Euroespes

The revenue cannot currently be calculated for Euroespes.

The profit cannot currently be calculated for Euroespes.

The P/E ratio cannot be calculated for Euroespes at the moment.

The P/S cannot be calculated for Euroespes currently.

The Eulerpool Quality Score for Euroespes is 1/10.

The ISIN of Euroespes is ES0133421000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Euroespes is EEP.MC. The ticker symbol is used to trade Euroespes shares on the stock exchange.

Fair ValueTerminal
0.28 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
EUR
Initial public offering
Jun 21, 2012
ISIN
ES0133421000
Cusip
E4708B107
Market capitalization
4.02 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
77.25
P/B Ratio
1.52
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.02 %
Last updated Oct 10, 2026, 5:53 PM

Euroespes Peer Group

Euroespes FIGI

EEP:SM · BBG001J2P2C7EEP:SQ · BBG001J2P2J0EEP3EUR:XH · BBG012814311EEP3EUR:XF · BBG012814339EEP3EUR:XE · BBG012814357EEP3EUR:XL · BBG012814375EEP3EUR:XG · BBG012814384EEP3EUR:XO · BBG012814393EEP3EUR:XA · BBG0128143F6EEP3EUR:XT · BBG0128143H4EEP3EUR:XW · BBG0128143J2EEP3EUR:XU · BBG0128143K0

All fundamentals and in-depth analysis of Euroespes

Our stock analysis for Euroespes stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Euroespes. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.